Literature DB >> 6849763

Specific measurement of 5-aminosalicylic acid and its acetylated metabolite in human bile.

C Fischer, K Maier, U Klotz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6849763      PMCID： PMC1427861          DOI： 10.1111/j.1365-2125.1983.tb01499.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Simplified high-performance liquid chromatographic method for 5-aminosalicylic acid in plasma and urine.

Authors:  C Fischer; K Maier; U Klotz
Journal:  J Chromatogr       Date:  1981-10-09

2.  Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.

Authors:  M Campieri; G A Lanfranchi; G Bazzocchi; C Brignola; F Sarti; G Franzin; A Battocchia; G Labo; P R Dal Monte
Journal:  Lancet       Date:  1981-08-08       Impact factor: 79.321

3.  Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.

Authors:  U Klotz; K Maier; C Fischer; K Heinkel
Journal:  N Engl J Med       Date:  1980-12-25       Impact factor: 91.245

4.  The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man.

Authors:  A K Azadkhan; S C Truelove; J K Aronson
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

5.  Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.

Authors:  P A van Hees; J H Bakker; J H van Tongeren
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

6.  An experiment to determine the active therapeutic moiety of sulphasalazine.

Authors:  A K Azad Khan; J Piris; S C Truelove
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321
  6 in total
  6 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

3.  Disposition of 5-aminosalicylic acid, the active metabolite of sulphasalazine, in man.

Authors:  C Fischer; K Maier; E Stumpf; U von Gaisberg; U Klotz
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Kinetics of 5-aminosalicylic acid after jejunal instillation in man.

Authors:  O Haagen Nielsen; S Bondesen
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

5.  Pharmacokinetics of 5-aminosalicylic acid in man following administration of intravenous bolus and per os slow-release formulation.

Authors:  S Bondesen; J Hegnhøj; F Larsen; S H Hansen; C P Hansen; S N Rasmussen
Journal:  Dig Dis Sci       Date:  1991-12       Impact factor: 3.199

6.  Oroileal transit of slow release 5-aminosalicylic acid.

Authors:  H Goebell; U Klotz; B Nehlsen; P Layer
Journal:  Gut       Date:  1993-05       Impact factor: 23.059
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.